Intracellular signaling of the Ufo/Axl receptor tyrosine kinase is mediated mainly by a multi-substrate docking-site - PubMed (original) (raw)
. 1997 Jun 5;14(22):2619-31.
doi: 10.1038/sj.onc.1201123.
Affiliations
- PMID: 9178760
- DOI: 10.1038/sj.onc.1201123
Intracellular signaling of the Ufo/Axl receptor tyrosine kinase is mediated mainly by a multi-substrate docking-site
J Braunger et al. Oncogene. 1997.
Abstract
Ufo/Axl belongs to a new family of receptor tyrosine kinases with an extracellular structure similar to that of neural cell adhesion molecules. In order to elucidate intracellular signaling, the cytoplasmic moiety of Ufo/Axl was used to screen an expression library according to the CORT (cloning of receptor targets) method. Three putative Ufo substrates were identified: phospholipase Cgamma1 (PLCgamma), as well as p85alpha and p85beta subunits of phosphatidylinositol 3'-kinase (PI3-kinase). Subsequently, chimeric EGFR/Ufo receptors consisting of the extracellular domains of the epidermal growth factor receptor (EGFR) and the transmembrane and intracellular moiety of Ufo were engineered. Using different far-Western blot analyses and coimmunoprecipitation assays, receptor binding of PLCgamma and p85 proteins as well as GRB2, c-src and lck was examined in vitro and in vivo. Competitive inhibition of substrate binding and mutagenesis experiments with EGFR/Ufo constructs revealed C-terminal tyrosine 821 (EILpYVNMDEG) as a docking site for multiple effectors, namely PLCgamma, p85 proteins, GRB2, c-src and lck. Tyrosine 779 (DGLpYALMSRC) demonstrated an additional, but lower binding affinity for the p85 proteins in vitro. In addition, binding of PLCgamma occurred through tyrosine 866 (AGRpYVLCPST). Moreover, our in vivo data indicate that further direct or indirect binding sites for PLCgamma, GRB2, c-src and lck on the human Ufo receptor may exist.
Similar articles
- In brain, Axl recruits Grb2 and the p85 regulatory subunit of PI3 kinase; in vitro mutagenesis defines the requisite binding sites for downstream Akt activation.
Weinger JG, Gohari P, Yan Y, Backer JM, Varnum B, Shafit-Zagardo B. Weinger JG, et al. J Neurochem. 2008 Jul;106(1):134-46. doi: 10.1111/j.1471-4159.2008.05343.x. Epub 2008 Jul 1. J Neurochem. 2008. PMID: 18346204 Free PMC article. - Cytoplasmic ACK1 interaction with multiple receptor tyrosine kinases is mediated by Grb2: an analysis of ACK1 effects on Axl signaling.
Pao-Chun L, Chan PM, Chan W, Manser E. Pao-Chun L, et al. J Biol Chem. 2009 Dec 11;284(50):34954-63. doi: 10.1074/jbc.M109.072660. Epub 2009 Oct 8. J Biol Chem. 2009. PMID: 19815557 Free PMC article. - Differential activation of the Ras/extracellular-signal-regulated protein kinase pathway is responsible for the biological consequences induced by the Axl receptor tyrosine kinase.
Fridell YW, Jin Y, Quilliam LA, Burchert A, McCloskey P, Spizz G, Varnum B, Der C, Liu ET. Fridell YW, et al. Mol Cell Biol. 1996 Jan;16(1):135-45. doi: 10.1128/MCB.16.1.135. Mol Cell Biol. 1996. PMID: 8524290 Free PMC article. - Grb2 binding to the different isoforms of Ret tyrosine kinase.
Alberti L, Borrello MG, Ghizzoni S, Torriti F, Rizzetti MG, Pierotti MA. Alberti L, et al. Oncogene. 1998 Sep 3;17(9):1079-87. doi: 10.1038/sj.onc.1202046. Oncogene. 1998. PMID: 9764818 - Mitogenic signals and transforming potential of Nyk, a newly identified neural cell adhesion molecule-related receptor tyrosine kinase.
Ling L, Kung HJ. Ling L, et al. Mol Cell Biol. 1995 Dec;15(12):6582-92. doi: 10.1128/MCB.15.12.6582. Mol Cell Biol. 1995. PMID: 8524223 Free PMC article.
Cited by
- Gas6 induces growth, beta-catenin stabilization, and T-cell factor transcriptional activation in contact-inhibited C57 mammary cells.
Goruppi S, Chiaruttini C, Ruaro ME, Varnum B, Schneider C. Goruppi S, et al. Mol Cell Biol. 2001 Feb;21(3):902-15. doi: 10.1128/MCB.21.3.902-915.2001. Mol Cell Biol. 2001. PMID: 11154277 Free PMC article. - Two-Front War on Cancer-Targeting TAM Receptors in Solid Tumour Therapy.
Mikolajczyk A, Mitula F, Popiel D, Kaminska B, Wieczorek M, Pieczykolan J. Mikolajczyk A, et al. Cancers (Basel). 2022 May 18;14(10):2488. doi: 10.3390/cancers14102488. Cancers (Basel). 2022. PMID: 35626092 Free PMC article. Review. - AXL Receptor in Cancer Metastasis and Drug Resistance: When Normal Functions Go Askew.
Auyez A, Sayan AE, Kriajevska M, Tulchinsky E. Auyez A, et al. Cancers (Basel). 2021 Sep 28;13(19):4864. doi: 10.3390/cancers13194864. Cancers (Basel). 2021. PMID: 34638349 Free PMC article. Review. - Altered expression of AXL receptor tyrosine kinase in gastrointestinal cancers: a promising therapeutic target.
Pidkovka N, Belkhiri A. Pidkovka N, et al. Front Oncol. 2023 Jul 4;13:1079041. doi: 10.3389/fonc.2023.1079041. eCollection 2023. Front Oncol. 2023. PMID: 37469409 Free PMC article. Review. - Molecular insights of Gas6/TAM in cancer development and therapy.
Wu G, Ma Z, Hu W, Wang D, Gong B, Fan C, Jiang S, Li T, Gao J, Yang Y. Wu G, et al. Cell Death Dis. 2017 Mar 23;8(3):e2700. doi: 10.1038/cddis.2017.113. Cell Death Dis. 2017. PMID: 28333143 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous